As of September 30, 2026, Ocugen, Inc. carries a market capitalization of 349.49M, placing it among publicly traded companies globally. Its enterprise value stands at 353.79M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 349.49M |
| Enterprise Value | 353.79M |
Ocugen, Inc.'s next confirmed earnings release is scheduled for March 10, 2027.
| Earnings Date | 3/10/2027 |
As of September 30, 2026, Ocugen, Inc. has 339.31M shares outstanding.
| Shares Outstanding | 339.31M |
These figures are as of September 30, 2026. The price-to-sales ratio is 71.00, and the price-to-book ratio stands at -19.77.
| PS Ratio | 71.00 |
| PB Ratio | -19.77 |
| P/TBV Ratio | -19.77 |
| P/FCF Ratio | -5.31 |
| P/OCF Ratio | -5.33 |
These figures are as of September 30, 2026. The EV/Sales ratio of 74.03 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 353.79M versus a market cap of 349.49M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 74.03 |
As of September 30, 2026, Ocugen, Inc. maintains a current ratio of 0.77, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -500.89, indicating conservative leverage, while an interest coverage ratio of -6.63 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.77 |
| Quick Ratio | 0.71 |
| Debt / Equity | -500.89 |
| Debt / EBITDA | -1.31 |
| Interest Coverage | -6.63 |
These figures cover the twelve months ended September 30, 2026. Return on assets (ROA) is negative at -78.91, reflecting losses generated across the asset base. The company generates approximately 41,198.28 in revenue per employee across its workforce of 116.00, a quick read on workforce productivity versus industry peers.
| Return on Assets (ROA) | -78.91 |
| Revenue Per Employee | 41,198.28 |
| Employee Count | 116.00 |
As of the close on November 16, 2026, Ocugen, Inc.'s stock has declined approximately 35.04% over the past 52 weeks. The 50-day moving average sits at 0.92, while the 200-day moving average is 1.39.
| 52-Week Price Change | -35.04% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 1.39 |
Over the twelve months ended September 30, 2026, Ocugen, Inc. generated 4.78M in revenue and converted that into -65.36M in net income, yielding earnings per share of -0.20. EBITDA reached -67.70M, while operating income came in at -69.03M.
| Revenue | 4.78M |
| Operating Income | -69.03M |
| Pretax Income | -65.36M |
| Net Income | -65.36M |
| EBITDA | -67.70M |
| EBIT | -69.03M |
| Earnings Per Share (EPS) | -0.20 |
As of September 30, 2026, Ocugen, Inc. holds 84.26M in cash and equivalents against 88.56M in total debt, resulting in a net debt position of 60.26M. Total book value stands at -17.68M, with working capital of -27.47M providing operational flexibility.
| Cash & Cash Equivalents | 84.26M |
| Total Debt | 88.56M |
| Net Debt | 60.26M |
| Equity (Book Value) | -17.68M |
| Book Value Per Share | -0.05 |
| Working Capital | -27.47M |
Ocugen, Inc. produced -63.69M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -211,000.00 in capital expenditures, free cash flow totaled -63.90M - equivalent to -0.19 per share.
| Operating Cash Flow | -63.69M |
| Capital Expenditures | -211,000.00 |
| Free Cash Flow | -63.90M |
| FCF Per Share | -0.19 |
These figures cover the twelve months ended September 30, 2026. The operating margin of -1,444.47 and net profit margin of -1,367.61 provide insight into operational efficiency.
| Operating Margin | -1,444.47 |
| Pretax Margin | -1,367.61 |
| Profit Margin | -1,367.61 |
| EBITDA Margin | -1,416.70 |
These figures cover the twelve months ended September 30, 2026. Free cash flow yield is negative at -18.83: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -33.05, meaning Ocugen, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -33.05 |
| FCF Yield | -18.83 |
Ocugen, Inc.'s most recent stock split took place on September 30, 2019 with a 60:1 split ratio.
| Last Split Date | 9/30/2019 |
| Split Ratio | 60:1 |
As of September 30, 2026, Ocugen, Inc. has an Altman Z-Score of -6.61, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -6.61 |